Cargando…
Conventional Treatments Cannot Improve Outcomes of Early-Stage Primary Breast Marginal Zone Lymphoma
INTRODUCTION: Primary breast marginal zone lymphoma (PBMZL) is a rare occurrence and less is known about its characteristics, treatments, and outcomes. METHODS: We retrospectively reviewed 370 cases of early-stage PBMZL from the Surveillance, Epidemiology, and End Results database. Statistical analy...
Autores principales: | Liu, Hailing, Zhang, Jing, Quan, Lin, Cao, Lei, Miao, Yi, Zhao, Xiaoli, Shen, Haorui, Wang, Li, Xu, Wei, Li, Jianyong, Fan, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076799/ https://www.ncbi.nlm.nih.gov/pubmed/33928019 http://dx.doi.org/10.3389/fonc.2020.609512 |
Ejemplares similares
-
First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
por: Liu, Hailing, et al.
Publicado: (2022) -
Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma
por: Lin, Huahang, et al.
Publicado: (2022) -
Murine Models of Splenic Marginal Zone Lymphoma: A Role for Cav1?
por: Patten, Chelsey L., et al.
Publicado: (2016) -
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023) -
Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential
por: Robinson, Jacob E., et al.
Publicado: (2020)